Search for: "MYLAN TECHNOLOGIES INC."
Results 81 - 100
of 149
Sort by Relevance
|
Sort by Date
15 Feb 2011, 5:26 pm
(FDA Law Blog) Diovan (Vasartan) – France: Novartis v Actavis – preliminary injunction for Valsartan confirmed (The SPC Blog) Diovan HTC (Valsartan) – Belgium: Antwerp Court of Appeal stops infringement of Valsartan/HCTZ SPC based on patent claiming Valsartan alone: Novartis v Teva (The SPC Blog) Lescol (Fluvastatin) – US: Novartis files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) (GenericsWeb) Mucinex (Guaifenesin) –… [read post]
22 Dec 2010, 3:01 am
Mylan Inc. et al. [read post]
15 Dec 2010, 2:17 am
General Coming soon: International Classification of traditional medicine by WHO (Spicy IP) Teva Pharma uses online game to promote generic substitution (Patent Baristas) Australia: APO: Success of phase 3 trials ‘obvious’ in view of phase 1 and 2: Genentec, Inc (Patentology) Brazil: Government support to impel Brazil generic market (GenericsWeb) EU: EPO Enlarged Board of Appeal decides Broccoli (G2/07) and Tomatoes (G1/08) – essentially biological breeding processes not… [read post]
14 Dec 2010, 9:29 pm
Mylan... [read post]
8 Dec 2010, 2:20 am
(America-Israel Patent Law) Ziagen (Abacavir) – US: Mylan’s Matrix receives tentative FDA approval under PEPFAR for Abacavir Sulfate tablets, 60 mg (SmartBrief) [read post]
1 Dec 2010, 12:15 am
Abraxis Bioscience, Inc. v. [read post]
24 Nov 2010, 12:37 am
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an… [read post]
28 Sep 2010, 3:14 pm
Par Pharmaceutical, Inc; Schering-Plough Healthcare Products, Inc. et al. v. [read post]
24 Sep 2010, 1:15 pm
Mylan Labs, Inc., 520 F.3d 1358 (Fed. [read post]
7 Sep 2010, 6:10 pm
Genpharm Inc. et al. [read post]
2 Sep 2010, 10:51 am
Mylan Labs, Inc., 520 F.3d 1358 (Fed. [read post]
28 Jul 2010, 12:06 am
(Patent Docs) Namenda (Memantine) – US: Mylan announces settlement agreement with Forest Lab’s and Merz Pharmaceuticals (SmartBrief) Olux-E (Clobetasol) – US: Patent infringement complaint following a Paragraph IV certification: Stiefel Laboratories Inc. et al. v. [read post]
22 Jul 2010, 11:59 am
Mylan Labs., Inc., 464 F.3d 1286, 1289 (Fed. [read post]
7 May 2010, 11:11 am
United Technologies Corp. [read post]
22 Apr 2010, 3:51 am
Paddock Laboratories, Inc. [read post]
15 Apr 2010, 9:20 am
Cal. 1996); Summit Technology, Inc. v. [read post]
31 Mar 2010, 1:58 pm
Prods., Inc. v. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
5 Mar 2010, 9:10 pm
Mylan Labs., Inc., 520 F.3d 1358, 1364-65 (Fed. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to… [read post]
